Problems and advantages of continuous renal replacement therapy

Nephrology

Volumn 7, Issue 3, 2002, Pages 110-114

  Thomas, Merlin C ^a   Harris, David C H ^a,b  

^a WESTMEAD HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Acute renal failure; Continuous renal replacement therapy; Haemofiltration; Heamodialysis; Ultrafiltration

Indexed keywords

ANTICOAGULANT AGENT; CITRIC ACID; HEPARIN; LACTIC ACID; PROSTACYCLIN;

ANTICOAGULATION; BIOCOMPATIBILITY; BLEEDING; CARDIOVASCULAR SYSTEM EXAMINATION; CONVALESCENCE; DIALYSIS; FLUID BALANCE; GRAFT SURVIVAL; HEMODYNAMIC MONITORING; HEMOFILTRATION; HUMAN; INTERMETHOD COMPARISON; KIDNEY CLEARANCE; KIDNEY METABOLISM; KIDNEY TRANSPLANTATION; KIDNEY TUBULE ACIDOSIS; MEDIATOR RELEASE; MULTIPLE ORGAN FAILURE; NUTRITION; OUTCOMES RESEARCH; PERITONEAL DIALYSIS; POSTOPERATIVE THROMBOSIS; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; ULTRAFILTRATION;

EID: 0036046152     PISSN: 13205358     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1797.2002.00103.x     Document Type: Review

References (20)

1. Indications for long-term results and limitations of peritoneal dialysis
2. Nomenclature for chronic renal replacement therapies
3. What is the renal replacement method of first choice for intensive care patients?
4. Continuous haemofiltration in the intensive care unit
5. A critical examination of dialysis induced hypotension
6. Metabolic aspects of continuous renal replacement therapies
7. Effect of the hemodialysis prescription on patient morbidity: Report of the national cooperative dialysis study
8. Changing acute renal failure treatment from intermittent hemodialysis to continuous hemofiltration: Impact on azotemic control
9. Pharmacokinetic principles during continuous renal replacement therapy: Drugs and dosage
10. Lactate- or bicarbonate-buffered solutions in continuous extracorporeal renal replacement therapies
11. Anticoagulation in continuous renal replacement therapy
12. Continuous veno-venous hemofiltration without anticoagulation in high-risk patients
13. Is cytokine removal by continuous hemofiltration feasible?
14. Haemostatic changes in systemic inflammatory response syndrome during continuous renal replacement therapy
15. Cytokine removal and cardiovascular hemodynamics in septic patients with continuous hemofiltration
16. Influence of renal replacement therapy on outcome of patients with acute renal failure
17. Comparing continuous hemofiltration with hemodialysis in patients with severe acute renal failure
18. History and development of continuous renal replacement therapy
19. Acute dialytic support for the critically ill: Intermittent hemodialysis versus continuous arteriovenous hemodiafiltration
20. Cost effectiveness of continuous renal replacement therapy in the intensive care unit